Respicardia's Series E Round

Respicardia raised a round of funding on December 18, 2017. Investors include ZOLL Medical.

Respicardia, formerly Cardiac Concepts, is developing implantable therapies designed to improve respiratory and cardiovascular health. The company's initial product, the remede System, is an implantab…

Articles about Respicardia's Series E Round: